Search

everythinglearnresearchcommunity

for

Search:↓

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

COVID-19-related hair loss may have unique features compared to hair loss from other causes.

Woman's hair loss diagnosis changed from CTE to AA; multiple biopsies important for accurate diagnosis.

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

The paper suggests improving diagnosis and treatment of telogen effluvium but does not recommend a new classification system.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

Hair sheds gradually from the follicle, with readiness to shed indicated by less attachment material.

Hair loss in Cronkhite-Canada syndrome is reversible by treating the gut issues and doesn't need steroid treatment for the hair itself.

A baby's toe was severely damaged by a hair tourniquet, leading to bone and tendon damage, but improved after surgery and treatment.

The anti-CXCL4 antibody helps mice grow hair faster and prevents hair loss.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

Hair loss from Telogen Effluvium can be managed by treating the underlying cause and may improve with treatments like minoxidil.

Proteoglycans are important for hair growth, and a specific treatment can help reduce hair loss.

Hair loss from telogen effluvium may not happen again after another surgery.

A woman experienced temporary hair loss after jaw surgery due to the stress of the operation.

SB414 may be an effective treatment for atopic dermatitis by reducing swelling and bacterial infection.

DCP therapy causes side effects like weakness, flushing, headaches, and taste changes, but less frequently causes hypertension and diabetes.

The new oral testosterone pill normalized testosterone levels and lowered SHBG in men with low testosterone.

The amnion bilayer dressing improved healing and reduced scarring in full-thickness burns.

SIG-1451 could be a promising new treatment for atopic dermatitis.

A systematic approach is crucial for managing hair loss in women.

Dermoscopy shows that diffuse alopecia areata progresses through specific hair growth stages.

Fat-related cells are important for initiating hair growth.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Hormones, nutrition, and seasonal changes regulate hair growth cycles, with androgens extending growth phases and factors like aging and malnutrition affecting hair loss and thinning.

The document concludes that various cosmetic and drug treatments are available for hirsutism, and some new drugs show promise.